Company Filing History:
4 out of 151 
Years Active: 2016-2018
Title: Innovations of Gregor Bramberger in Recombinant Protein Production
Introduction
Gregor Bramberger is an accomplished inventor based in Vienna, Austria. He has made significant contributions to the field of biotechnology, particularly in the production of recombinant proteins. With a total of two patents to his name, Bramberger's work focuses on enhancing the efficiency of cell culture conditions for producing high molecular weight von Willebrand factor (vWF) and ADAMTS13.
Latest Patents
Gregor Bramberger's latest patents include a method of producing recombinant high molecular weight vWF in cell culture. This invention relates to optimizing cell culture conditions to produce highly multimeric vWF with high specific activity. The method involves using a cell culture medium with increased copper concentration and a supernatant with low ammonium concentration. Additionally, he has developed a method for producing recombinant ADAMTS13 in cell culture, which shares similar cell culture conditions aimed at enhancing the expression of these important proteins.
Career Highlights
Bramberger is currently associated with Baxalta GmbH, a company known for its focus on biotechnology and pharmaceuticals. His work at Baxalta has allowed him to explore innovative solutions in the production of therapeutic proteins, contributing to advancements in medical treatments.
Collaborations
Some of his notable coworkers include Leopold Grillberger and Manfred Reiter. Their collaboration has likely fostered a productive environment for research and development in the field of recombinant protein production.
Conclusion
Gregor Bramberger's innovative approaches in the biotechnology sector have led to significant advancements in the production of recombinant proteins. His patents reflect a commitment to improving cell culture techniques, which can have a profound impact on therapeutic applications.